Clinical Trial Update: The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure [Phase 2]

View source ↗

Summary

A Phase 2 trial studying liraglutide in patients with chronic kidney disease and prediabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Prediabetes

Drugs mentioned

• Victoza (Liraglutide)

Snippet

Sponsor: Bo Feldt-Rasmussen | Conditions: Kidney Failure, Chronic, Prediabetic State | Phase 2 | Status: WITHDRAWN